Objective. Barriers to guideline-based diabetes care include poor patient activation, haphazard clinic appointments, poorly organized medical records and a lack of automated physician decision support. We developed a patient recall intervention to mitigate these barriers and improve diabetes care coordination. We evaluated this intervention in terms of operational feasibility, provider and patient acceptance and effects on process of care measures.
Background
Guidelines for care promulgated by the American Diabetes Association (ADA) [1] specify intervals for receiving diabetes-related medical services in order to promote glycemic control and minimize complications. Nonetheless, large numbers of patients with diabetes in ambulatory clinic populations are not up to date with guideline-based evaluations. In outpatient settings, the delivery of chronic disease services is suboptimal [2 -4] . Clinic visits are often too brief for medical providers to review and arrange for all recommended care. Providers are frequently hampered by poorly organized clinical data and a lack of automated reminders. Most patients do not know about recommendations for care and tend to focus on acute concerns during clinic visits. Finally, many patients fail to make clinic appointments or do so for reasons unrelated to their chronic illness.
To overcome many of these barriers, we developed a health promotion outreach system [5] . The purpose of this system is to increase access to and enhance the delivery of guideline-based care by communicating with patients outside of clinical settings. Our diabetes-specific outreach system incorporates: (a) electronic queries of administrative claims to identify patients who are not up to date with recommended diabetes services; (b) an outreach coordinator with a bachelor's degree who provides mail and telephone outreach to alert patients about recommendations for care and facilitate the immediate scheduling of services and (c) to improve visit planning, advance provider notification about the intended diabetes focus of appointments arranged through the outreach process.
Although a small number of primary care practices have been performing sophisticated diabetes recall activities, none, to our knowledge, have been previously described in the peer-reviewed literature. The purpose of this pilot study was to assess whether a novel outreach intervention is operationally feasible, improves the timely receipt of diabetes-related medical services as well as clinical attention to diabetes during primary care visits, and is acceptable to providers.
Methods

Study setting
This study was carried out in a general internal medicine practice affiliated with the University of Colorado Hospital. The practice provides primary care to a diverse patient population (approximately 50 000 visits per year) and is staffed by 31 attending physicians, 4 nurse practitioners and 12 primary care residents.
Diabetes-related medical services
On the basis of the ADA criteria [1] , we developed an intervention focused on achieving patient adherence with at least two hemoglobin A1c determinations and single urine microalbumin and serum creatinine laboratory yearly. The intervention also promoted the ADA's primary recommendation of retinal exams and lipid profiles on a yearly basis. Finally, although not an explicit ADA recommendation, clinic appointments were recommended to patients who had not seen their provider in over 6 months, because as a practical matter it is difficult to allocate clinician time to reinforce disease management principles and review disease status and laboratories, including twice-yearly A1c laboratories, outside the context of such visits.
Patient population
To identify ongoing recipients of diabetes care within the clinic, patients were included in a patient registry if they had a record of at least two provider visits at any point in time associated with a 250.xx ICD-9 code within our billing claims system. In order to minimize outreach to patients no longer receiving care from one of our providers, we omitted patients whose last primary care visit was more than 18 months in the past. Because services could be scheduled 30 days into the future, patients were deemed eligible for outreach if they were coming due for at least one service during the next month. This means patients were excluded if they had an administrative claim for a primary care visit or hemoglobin A1c laboratory in the past 5 months (150 days) and a retinal exam, fasting lipid profile and microalbumin/creatinine ratio within the past 11 months (330 days). Patients were also ineligible for outreach if they had a pending provider appointment within the next 6 weeks or had received an outreach letter during the previous 60 days. Supplementing this automated, claims-based algorithm, an outreach coordinator carried out a brief review of the electronic medical record (Allscripts Touchworks v. 10, Chicago, IL, USA) to exclude patients who were deceased, had cancer or a terminal diagnosis, or were receiving ongoing diabetes care through an endocrinologist or within a nursing home.
Intervention description and implementation
All providers pre-authorized the intervention team to identify and telephonically schedule recommended services for eligible patients. Administrative claims queries were updated on a monthly basis, and patient records were imported into information management software that we developed for this and other prevention and chronic disease outreach interventions [5] . The software generated patient invitation letters that included the name of each patient's provider, summarized the ADA recommendations and encouraged patients to contact our call center to arrange for overdue services. Letters were accompanied by postage-paid return postcards on which patients could indicate whether they recently received services outside of our health system, no longer received primary care within our system, were uninterested in the recommended services, or preferred for us to contact them at a specified time and phone number. If patients did not respond to the letters within 2 weeks by postcard or telephone, the outreach coordinator made up to three calls to their homes, leaving a voice message on the first attempt. Patients who could not be reached within 8 weeks were regarded as decliners of diabetes services. If telephone contact was established, the outreach coordinator reviewed the recommendations for care and, if patients accepted, the outreach coordinator immediately scheduled services including, whenever possible, laboratories at least a day (but preferably a week) before provider visits. The outreach coordinator then requested provider authorization for the identified services by means of the electronic medical record. This process assured that the electronic orders originated with the provider (for billing and compliance), that results were returned directly to the provider (for clinical follow-up) and that the transaction was documented in the electronic medical record. After the orders were approved, the outreach coordinator mailed reminder postcards to patients noting the date, time and location of the services. The outreach coordinator then sent informational notes to providers notifying them via the electronic medical record of all scheduled services and the diabetes-specific purpose of pending provider appointments. The call center was open between 8 and 19 h, Monday to Thursday; at other times patients could leave messages requesting a callback.
Following 1 month of pilot testing (March 2007), we conducted intervention outreach over 3 months (1 April to 30 June 2007) after which we halted the process in order to evaluate outcomes that would inform a decision about whether to continue the program in the study clinic as well as deploy it in other clinics.
Process measures
We assessed the following: (1) The number and proportion of patients in the diabetes registry who over the intervention period received outreach for provider visits and/or laboratory testing (2) The number, proportion and sociodemographic characteristics of patients who completed provider visits arranged through outreach A primary intervention effect was based on whether patients completed a provider visit scheduled by an outreach coordinator. Although outreach letters explicitly instructed patients to contact our call center, some patients bypassed this mechanism and instead called the clinic directly to schedule provider visits. Thus, we determined a secondary intervention effect based on whether patients self-scheduled and completed diabetes-related services within 6 weeks of the date invitation letters were mailed. (3) Among patients who completed provider visits arranged through outreach, the degree to which care associated with the intervention differed from traditional care these same patients had received most recently in the past 3 years when they were also overdue for a provider visit. On the basis of the medical record review, we evaluated several aspects of diabetes care at two points in time. The first was care rendered during provider visits arranged through outreach and including follow-up visits that took place within 1 month afterwards (interventionrelated care). The second was care rendered before implementation of the outreach intervention at a point when provider visits were most recently overdue and within 1 month afterwards (traditional care). Based on electronic medical record review of a random sample of 50 patients who completed outreach-scheduled provider visits, we compared intervention and traditional care in terms of the average number of days between overdue provider visits, average number of services for which patients were due, specific services obtained and clinical actions related to diabetes documented in the electronic medical record, including referrals for diabetes education or endocrinology consultations; modification of antihyperglycemics, antihypertensives and lipid-lowering agents; and provider review of diabetes-specific laboratory and physical exam findings. This type of traditional care comparison was warranted because only certain patients would be responsive to outreach and, using the best data available, the objective was to gain insight into whether care was improved for this group of patients.
(4) Clinician satisfaction with the intervention. We devised a brief, anonymous online survey that we administered to providers in order to assess their open-ended opinions about the intervention's ease of use and mechanics, its effects on quality of care, and feedback received from patients.
Statistical methods
Statistical procedures were carried out using STATA (version 8.2, College Station, TX, USA). We used chi-square tests to determine the unadjusted strength of association and multivariable logistic regression to determine the adjusted strength of association between sociodemographic characteristics (age, sex, race/ethnicity, type of insurance and marital status) and completion of services, and to compare aspects of traditional care with the intervention among patients who responded to outreach. Variables whose level of significance in bivariate analysis was 0.25 or less were included in multivariable modeling [6] . Student's t-tests were used to compare the intervention and traditional care in terms of average numbers of laboratories due and average number of days overdue for provider visits.
Institutional review board
This intervention was designed and carried out as a quality improvement program that relied on standard methods for creating patient registries and providing patient outreach. The Colorado Multiple Institutional Review Board approved publication of results following the removal of personal health information.
Results
Outreach eligible population and provider visit completion Fig. 1 depicts the responsiveness of patients to outreach. Over a 3-month period, we identified 709 patients due for diabetes-related services (a monthly average of 18% of all patients in the diabetes registry). Of these, 415 were due for a provider visit ( Table 1 ). The proportion who completed such visits arranged by an outreach coordinator was 30.1% (n ¼ 125) and the proportion of these who completed laboratory testing at least a day before the provider visit was 80.8% (n ¼ 101). In adjusted analyses, men were more likely than women (OR ¼ 1.6, 95% CI ¼ 1.1 -2.5) and patients with Medicaid/low-income health insurance were less likely than those with Medicare to complete a provider visit (OR ¼ 0.4, 95% CI ¼ 0.2-0.9). After invitation letters were mailed, 65 patients bypassed an outreach coordinator to complete a provider visit that they self-scheduled directly through the clinic. Based on the chart review, providers documented attention to diabetes during 80% of these visits (n ¼ 52). After including these additional patients who selfscheduled for apparently diabetes-related reasons, the proportion due for provider visits that directly or indirectly responded to outreach was as high as 42.7%, although an unknowable percentage would have scheduled an appointment regardless of receiving an outreach letter. Of the 57.3% that did not complete a provider visit, approximately one-third could not be reached by the outreach coordinator and two-thirds refused for a variety of reasons (see Fig. 1 ).
Intervention and traditional care comparisons
On the basis of a random chart review of 50 patients who completed a provider visit arranged through outreach, the average number of days was 278 (9.1 months) between this visit and the first preceding visit that diabetes care was documented in the medical record. By comparison, the elapsed time between the historically most recent overdue diabetesrelated provider visit and the preceding one was 266 days, a non-significant difference (P ¼ 0.7). The average number of laboratories due at outreach and traditional care visits was 3.4 and 2.9, respectively, also a non-significant difference (P ¼ 0.2). Patient adherence with recommended laboratory testing, referrals for retinal exams, any provider comment related to diabetes and any combination of diabetes education, endocrinologist consultations and/or modification of pharmacologic therapy were all significantly more common during provider visits arranged through outreach compared with traditional care (Table 2) .
Provider feedback
Twenty-eight of 31 providers shared their opinions about the intervention through an anonymous online survey. The vast majority of provider attitudes were favorable. Illustrative comments included: 'Patients have been pleased with the intervention', 'I think the intervention helps build a relationship with my patients because they know we care about their health even between MD visits', 'It is terrific; we need more of these automatic items', 'Overall, an excellent option. It helps "fill in the gaps" when there are things that just can't be covered in a routine visit'. A small number of providers did report patient concerns. For example, one provider remarked, 'I have had at least 2 patients tell me they would not want anyone other than me ordering their tests, and they refused on the phone and then wanted to get my opinion before going through with [the outreach]'. Anecdotally, the outreach coordinator reported that many patients appreciated that providers were 'keeping track' of their health between visits and that the process of scheduling diabetes services was so convenient.
Conclusions
Among patients overdue for recommended services, and in comparison with traditional care, an enhanced reminder/recall intervention was associated with a substantially greater level of concordance with ADA-recommended intervals for diabetes-related laboratories and retinal exam referrals and with more intensive diabetes management during primary care visits. Over 40% of patients completed a diabetes focused provider visit when recommended in writing or over the phone by an outreach coordinator, and over 80% of those scheduled a provider visit through an outreach coordinator completed laboratories several days in advance of this visit. Only administrative claims data were used to identify eligible patients and an outreach coordinator with a bachelor's degree, rather than a nurse, carried out all tasks related to patient communication, scheduling and provider notification. Finally, providers expressed a high degree of satisfaction and interest in the intervention.
This unique outreach program is likely to have reduced several barriers associated with traditional care. First, we proactively contacted patients to inform them about recommendations for care instead of waiting for them to make appointments haphazardly and often for reasons unrelated to diabetes. We made daytime and evening telephone calls to patients, many of whom were undoubtedly busy or forgetful, when they did not themselves call in response to letters that summarized personalized recommendations. We scheduled all laboratories and provider visits at a single point in time, over the phone, and then sent reminder postcards that summarized this information. Rather than completing laboratory testing during provider visits, which would have required providers to convey recommendations for care several days later, we scheduled laboratories ahead of time whenever possible so that timely information would be available help guide clinical decision-making at the point of care. Finally, we notified providers in advance about the diabetes-specific purpose of appointments scheduled through the outreach coordinator.
Men were somewhat more responsive to outreach than women. Because women, in general, were more likely than men to be up to date with provider visits, those who were Based on a 50-patient random chart review of 125 patients who completed a provider visit arranged through outreach. Shown are proportions of patients due for indicated services who completed them except that diabetes education referrals and modification of pharmacologic therapy reflect frequency of documentation in the medical record without reference to whether these were due. not may represent a group that is more refractory to outreach. Patients with Medicaid and other low-income forms of insurance were less responsive to outreach than those with other health plans. This substantiates in actual practice an earlier survey of patients in the same setting in that socioeconomically disadvantaged patients were more reticent than other groups about the concept of health promotion outreach [7] . It also mirrors the results of a similar intervention designed to promote bone densitometry testing in average-risk women [8] . It is possible that socially vulnerable patients misunderstand or distrust the purpose of the intervention or are less able to respond to outreach because of greater numbers of practical barriers (e.g. transportation difficulties, taking time off from work and child care). On the other hand, individuals with commercial health plans also appear to have been less responsive to outreach than other groups, perhaps because they are more likely to be employed and have difficulty taking time off from work. Although more than 50% of patients were unresponsive to the outreach program, a large number cited reasons that reflect potentially modifiable misconceptions or misunderstandings about the program or about diabetes. For example, direct provider endorsement and improved education might be beneficial for many patients who do not understand the purpose and mechanics of the outreach program or who downplay the significance of their diabetes.
The chronic care model elaborates key mechanisms for improving the care of patients with diabetes and other chronic illnesses [9 -11] . Our intervention facilitates guidelinebased care and promotes chronic care model elements through patient outreach. It offers a powerful mechanism for improving information flow between providers and patients. Continuous outreach also produces more accurate and up-to-date population registries (e.g. identifying patients who die, leave the healthcare system, move, and change phone numbers) than is possible without outreach. Finally, this type of outreach supports the chronic care model's focus on providing patient-centered care [12] . Through outreach, and in anticipation of provider visits, our outreach program provides additional channels for informing and educating patients; it streamlines access to care; and it results in better visit planning and coordination of care.
This study has several weaknesses. Because the outreach program operated in a single academic primary care practice, generalizability is limited. We evaluated only process of care measures, not intermediate or hard clinical outcomes (e.g. changes in hemoglobin A1c values or the development of retinopathy). Based on a prior work, it is found that outreach and decision support systems that are process based only may increase the cost of care without improving clinical outcomes, whereas systems that focus on clinical outcomes are more likely to decrease the overall cost of care [13] . With relatively little effort, however, the intervention can be enhanced and the evaluation period prolonged in order to more directly address clinical outcomes. Because the study was designed in collaboration with our hospital to evaluate the potential benefits of a new approach to chronic disease care, operational needs precluded a randomized controlled trial. A pre/postevaluation of outcomes, with patients serving as their own controls, could have potentially produced biased results if other improvements in diabetes care were occurring in the practice at the same time as this intervention, however, this was not the case. Finally, the follow-up period was only 3 months. Despite these limitations, the primary aims of the study were achieved, including assessing the operational feasibility and improvements in care associated with an outreach intervention, gaining insights about the responsiveness of patients to outreach, and evaluating provider interest and satisfaction in the pilot program.
Based on the promising results described above, we are enhancing our administrative claims-based diabetes program to include biometric, laboratory and medication information culled from the electronic medical record and expanding outreach to patients who are not meeting ADA goals for blood pressure, lipids and aspirin therapy. We will also facilitate patient access to diabetes educators who are based within our endocrinology practice. By including clinical outcomes and enhanced patient education, we are hopeful that the next generation of our health promotion outreach system will be associated with sustained improvements in clinical outcomes for a larger proportion of our patients with diabetes.
